<DOC>
	<DOCNO>NCT00424931</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness JNJ-17216498 compare modafinil placebo patient narcolepsy , without cataplexy .</brief_summary>
	<brief_title>A Safety Effectiveness Study Single Dose JNJ-17216498 Patients With Narcolepsy</brief_title>
	<detailed_description>This study new , experimental drug do assess safety tolerability , explore effectiveness treatment narcolepsy . Approximately 64 adult patient narcolepsy without cataplexy recruit study . Patients meet study criterion need stop take current narcolepsy and/ medication least 14 day check site 3 night . They randomly assign one 4 treatment arm ; patient equal chance receive placebo , 10 mg JNJ-17216498 , 50 mg JNJ-17216498 400 mg modafinil . Placebo active drug . Modafinil drug currently approve treat narcolepsy . Patients take medication one day receive study medication blind fashion , i.e . patient , doctor study sponsor know group patient patient complete study . The investigator sponsor monitor study occurrence possible side effect . In addition screen visit three night site , follow-up visit 7-10 day day study drug take . After follow-up visit , patient may resume previous narcolepsy medication . Medical history , physical examination , vision test , blood pressure , heart rate , temperature , ECGs check periodically . Blood sample take standard safety laboratory test well measurement drug blood level . The Maintenance Wakefulness Test do ass patient 's ability resist fall asleep reclining dark , quiet room ; involve complete 7 session dose 10 session dose . Patients two polysomnograms , test brain , muscle eye activity sleep , obtain record brain wave activity muscle eye movement . Polysomnograms obtain overnight , dose . Patients also complete brief questionnaires sleepiness status narcolepsy throughout study . Patients receive capsule contain either 10 mg JNJ-17216498 , 50 mg JNJ-17216498 , 400 mg modafinil and/or placebo one day . Seven capsule take orally morning two capsule take orally afternoon . Placebo contain active drug . Modafinil drug currently approve treat narcolepsy .</detailed_description>
	<mesh_term>Narcolepsy</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<criteria>diagnosis narcolepsy within past 5 year good general health history presence drug alcohol abuse current use prescription counter medication include asprin herbal supplement exception acetaminophen ( Tylenol ) use fluoxetine ( Prozac ) past 6 week use Xyrem past 4 week use tobacco product past 3 month caffeine consumption 5 cup tea , 3 cup coffee 8 can soda per day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>narcolepsy</keyword>
	<keyword>sleepiness</keyword>
</DOC>